Home > Food & Beverages > Nutraceuticals > Vitamins > Glucosinolates Market
Glucosinolates Market size was valued at more than USD 180 million in 2022 and is anticipated to record over 5.5% CAGR from 2023 to 2032. Public health awareness and availability of dietary supplements to promote industry expansion.
The prevalence of chronic and non-communicable diseases (NCD) among the global population would influence market progress. As per estimates by the World Health Organization (WHO), around 41 million people die from NCDs such as cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases each year. Such events would impose a major burden on healthcare across undeveloped countries in South-East Asia.
New public health awareness drives have promoted the consumption of cruciferous vegetables and supplements to boost their immune systems. The adoption of plant-based drugs and rising cases of allergies among the younger population will likely elevate the demand for glucosinolates supplements in the coming years.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Glucosinolates Market Size in 2022: | USD 180 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.5% |
2032 Value Projection: | USD 330 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 230 |
Tables, Charts & Figures: | 460 |
Segments covered: | Extract and Region |
Growth Drivers: | |
Pitfalls & Challenges: |
The limited research potential of the product along with the easy availability of substitutes may hamper the glucosinolates market development. Growing preference for numerous dietary supplements and low-cost formulated drugs has impacted the sales of plant-based supplements to some extent. However, the growing popularity of plant-derived drugs on e-commerce platforms and a consumer shift toward veganism and a green diet are estimated to favor the glucosinolates industry.